Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. MBX Biosciences Inc shares valued at $45,312 were purchased by Pescovitz Ora H. on Apr 08 ’25. At $5.89 per share, Pescovitz Ora H. acquired 7,693 shares. The insider’s holdings grew to 24,329 shares worth approximately $0.3 million following the completion of this transaction.
Also, GORDON CARL L purchased 143,170 shares, netting a total of over 1,551,963 in proceeds. Following the buying of shares at $10.84 each, the insider now holds 3,255,000 shares.
Before that, GORDON CARL L had added 47,502 shares to its account. In a trade valued at $468,793, the Director bought MBX Biosciences Inc shares for $9.87 each. Upon closing the transaction, the insider’s holdings increased to 47,502 shares, worth approximately $39.27 million.
As published in their initiating research note from Citizens JMP on April 10, 2025, MBX Biosciences Inc [MBX] has been a Mkt outperform and the price target has been revised to $38. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early October. As of October 08, 2024, JP Morgan has initiated its “an Overweight” rating for MBX. Earlier on October 08, 2024, Jefferies initiated its rating. Their recommendation was “a Buy” for MBX stock.
Analyzing MBX Stock Performance
During the last five days, there has been a surge of approximately 20.45%. Over the course of the year, MBX Biosciences Inc shares have dropped approximately -33.53%.
Support And Resistance Levels for MBX Biosciences Inc (MBX)
According to the 24-hour chart, there is a support level at 11.37, which, if violated, would cause prices to drop to 10.48. In the upper region, resistance lies at 12.74. The next price resistance is at 13.22. RSI (Relative Strength Index) is 66.22 on the 14-day chart, showing neutral technical sentiment.
